Clinical Trial Update: A Proof-of-Concept Study Investigating the Safety and Efficacy of ZT-031 on Hip Fracture Healing in Men and Postmenopausal Women [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study evaluating ZT-031 for hip fracture healing in men and postmenopausal women has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• ZT-031

Snippet

Sponsor: Zelos Therapeutics | Conditions: Hip Fracture | Phase 2 | Status: WITHDRAWN